1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H1, 2015

Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H1, 2015" provides data on the Glycogen Storage Disorders (GSD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glycogen Storage Disorders (GSD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glycogen Storage Disorders (GSD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 5
Glycogen Storage Disorders (GSD) 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Sanofi 27
Clinical Trial Overview of Sanofi 27
Promethera Biosciences S.A. 29
Clinical Trial Overview of Promethera Biosciences S.A. 29
Clinical Trial Overview of Top Institutes / Government 30
Dipartimento di Pediatria Salus Pueri 30
Clinical Trial Overview of Dipartimento di Pediatria Salus Pueri 30
Institut de Myologie 31
Clinical Trial Overview of Institut de Myologie 31
Aarhus University Hospital 32
Clinical Trial Overview of Aarhus University Hospital 32
Baylor Research Institute 33
Clinical Trial Overview of Baylor Research Institute 33
University College London 34
Clinical Trial Overview of University College London 34
University Hospital Hamburg-Eppendorf 35
Clinical Trial Overview of University Hospital Hamburg-Eppendorf 35
University of Copenhagen 36
Clinical Trial Overview of University of Copenhagen 36
University of Pittsburgh 37
Clinical Trial Overview of University of Pittsburgh 37
Five Key Clinical Profiles 38
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables

Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Region, 2015* 6
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Glycogen Storage Disorders (GSD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Glycogen Storage Disorders (GSD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 16
Glycogen Storage Disorders (GSD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Glycogen Storage Disorders (GSD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 27
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Promethera Biosciences S.A., 2015* 29
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dipartimento di Pediatria Salus Pueri, 2015* 30
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Myologie, 2015* 31
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2015* 32
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor Research Institute, 2015* 33
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University College London, 2015* 34
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Hamburg-Eppendorf, 2015* 35
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Copenhagen, 2015* 36
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015* 37

List of Figures

Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12
Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Glycogen Storage Disorders (GSD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Glycogen Storage Disorders (GSD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Glycogen Storage Disorders (GSD) to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 16
Glycogen Storage Disorders (GSD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Glycogen Storage Disorders (GSD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Glycogen Storage Disorders (GSD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Glycogen Storage Disorders (GSD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 57

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.